Online market researcher YouGov continues to grow rapidly, with three acquisitions in the last half-year spreading its global reach even faster.
By adding operations in the US, Germany and Denmark, the group tripled turnover to £6.1m for the six months to January, with the UK and the Middle East showing 43% organic growth. 'Normalised' pre-tax profits grew 117% to £5.2m, with a £27m fundraising swelling year-end cash levels to £14m.
To maintain organic growth, the UK business has been ‘refocused’, with ‘research brains’ hired to head each of YouGov's five market verticals. Joint chief executive Nadhim Zahawi says this will lead to involvement in more ‘strategic’ campaigns, rather than lower-margin and ad-hoc ‘tactical’ ones, making up for the lower margins arising from acquisitions.
As well as cost advantages, online market research offers other improvements over its traditional peers, with innovation a strong YouGov focus. ‘It remains the driving force,’ says joint chief executive Stephan Shakespeare, pointing to a forthcoming hedge fund joint venture in conjunction with investment bank and house broker Numis.
Other, older innovations are being rolled out in new territories such as the US and Germany. Allied to an online market research subsection that is expected to grow at a breakneck 21% in 2008 compared with wider industry growth of 4% in 2007, Numis sees the full-year bringing 33% earnings growth to 8p a share, ahead of 26% to 10.1p in 2009.
Profit taking has cut the shares down from their all-time peak of 205p a year ago to the present 151p, still well above our 90p tip in 2006. At these rates of growth they remain a firm hold despite a full-bodied p/e rating.
Growth Company Investor is the UK’s leading authority on small-cap and AIM companies. You can gain immediate access to all the recent share recommendations with no obligation, with a free 30-day trial. Click here to join today.
Market cap: £148.96m
PE Forecast: 18.9
Share price: 151.75p
More breaking news stories.
More extended feature articles.
And a depth of analysis you
can't find anywhere else.
Advertisement
VCT Report 2010 uncovers the money available
for investment in every single VCT, helping you get one step ahead in the race to attract funding for your unquoted, AIM-listed or PLUS-quoted
company.
Order VCT Report 2010 today using this online form
A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
A full year's subscription to What Investment magazine for £19.95, a whopping 58% off. Get the latest news, features and expert advice on ISAs, Investment Trusts and Funds, SIPPS, Investing for Children and much much
more. Find out more here.
is the definitive and most up-to-date guide to completing your self-assessment tax return, making sure that you get it right and on time, and showing how you can save tax. For more information and to order, click here or contact our marketing team on 020 7250 7056.
The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).
A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!
Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.
Advertisement
Delcam, the international seller of CAD/CAM software to the engineering, aerospace and healthcare sectors among others, is a cash-generative small-cap seeing recovery in its markets.
Bombed-out biotech play Antisoma is hoping two of its drugs will lead to good fortune after experiencing disaster with lung cancer treatment ASA404.
London pub operator The Capital Pub Company is seeing continuing sales growth on the back of a surprisingly resilient market.